These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16178893)

  • 1. 'Scirrhous' type hepatocellular carcinomas: a special reference to expression of cytokeratin 7 and hepatocyte paraffin 1.
    Matsuura S; Aishima S; Taguchi K; Asayama Y; Terashi T; Honda H; Tsuneyoshi M
    Histopathology; 2005 Oct; 47(4):382-90. PubMed ID: 16178893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological study of scirrhous hepatocellular carcinoma.
    Kurogi M; Nakashima O; Miyaaki H; Fujimoto M; Kojiro M
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1470-7. PubMed ID: 16911695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific characteristics of scirrhous hepatocellular carcinoma.
    Sugiki T; Yamamoto M; Taka K; Nakano M
    Hepatogastroenterology; 2009; 56(93):1086-9. PubMed ID: 19760947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
    Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minute scirrhous hepatocellular carcinomas undergoing different carcinogenetic processes.
    Fujii T; Zen Y; Nakanuma Y
    Pathol Int; 2007 Jul; 57(7):443-8. PubMed ID: 17587244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma.
    Uenishi T; Kubo S; Hirohashi K; Yamamoto T; Ogawa M; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1101-4. PubMed ID: 12845990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistological evaluation of single small hepatocellular carcinoma with negative staining of monoclonal antibody Hepatocyte Paraffin 1.
    Sugiki T; Yamamoto M; Aruga A; Takasaki K; Nakano M
    J Surg Oncol; 2004 Nov; 88(2):104-7. PubMed ID: 15499598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of aquaporin-1 in liver tumors.
    Mazal PR; Susani M; Wrba F; Haitel A
    Hum Pathol; 2005 Nov; 36(11):1226-31. PubMed ID: 16260277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.
    Nishihara Y; Aishima S; Kuroda Y; Iguchi T; Taguchi K; Asayama Y; Taketomi A; Kinukawa N; Honda H; Tsuneyoshi M
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1860-8. PubMed ID: 18823434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant].
    Zermani R; Charfi L; Kourda N; Farah F; Rammeh S; Trabelsi O; Zaouch A; Ben Jilani S
    Tunis Med; 2005 Jul; 83(7):419-21. PubMed ID: 16220700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is histological diagnosis of primary liver carcinomas with fibrous stroma reproducible among experts?
    Malouf G; Falissard B; Azoulay D; Callea F; Ferrell LD; Goodman ZD; Hayashi Y; Hsu HC; Hubscher SG; Kojiro M; Ng IO; Paterson AC; Reynes M; Zafrani ES; Emile JF
    J Clin Pathol; 2009 Jun; 62(6):519-24. PubMed ID: 19155239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.
    Lee YC; Pan HW; Peng SY; Lai PL; Kuo WS; Ou YH; Hsu HC
    Eur J Cancer; 2007 Mar; 43(4):736-44. PubMed ID: 17267202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological implications of immunohistochemically demonstrated mucin core protein expression in hepatocellular carcinoma.
    Ichikawa T; Yamamoto T; Uenishi T; Tanaka H; Takemura S; Ogawa M; Tanaka S; Suehiro S; Hirohashi K; Kubo S
    J Hepatobiliary Pancreat Surg; 2006; 13(3):245-51. PubMed ID: 16708303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
    Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma.
    Aishima S; Nishihara Y; Kuroda Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 May; 31(5):783-91. PubMed ID: 17460464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
    Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
    Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of bcl-2 mRNA and protein exression in hepatocellular carcinomas.
    Ravazoula P; Tsamandas AC; Kardamakis D; Gogos C; Karatza C; Thomopoulos K; Tepetes K; Kourelis T; Petsas T; Bonikos DS; Karavias D
    Anticancer Res; 2002; 22(3):1799-805. PubMed ID: 12168872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection.
    Kim SH; Lim HK; Lee WJ; Choi D; Park CK
    Eur J Radiol; 2009 Jan; 69(1):123-30. PubMed ID: 17976942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.